GL Capital
Signal active
Investment Firm
Overview
Established in 2010, GL Capital is a Greater China healthcare-focused, value-driven investment management group. Since inception, GL Capital has developed a reputation as the partner-of-choice for leading healthcare companies and demonstrated capability to add value to its portfolio companies.
Highlights
Founded
2010
Industry
Asset Management
Employees
0
Investment
11
Lead Investment
7
Exits
4
Stages
Late Stage Venture, Early Stage Venture
Investor Type
Private Equity Firm, Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
GL Capital, established in 2010 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture investments across Biotechnology, Pharmaceutical, Chemical, Venture Capital, Finance, Impact Investing, Health Care, Enterprise Software, Financial Services, Genetics. The organization boasts a portfolio of 11 investments, with an average round size of $112.3M and 4 successful exits. Their recent investments include Pharmaron, DCM Ventures, Aisling Capital, Legend Capital, Sangon Biotech. The highest investment round they participated in was $55.7B. Among their most notable exits are Pharmaron and DCM Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
GL Capital has made 11 investments. Their most recent investment was on Apr 19, 2023, when Sangon Biotech raised $290.4M.
investments
11
Diversity investments
0
Lead investments
7
Number of exits
4
Investments
11
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jun 07, 2022 | - | - | 72.9M |
| Jun 07, 2022 | Nest | Health Care | null |
| Nov 16, 2022 | Asia Pacific Medical Group | Health Care | null |
| Apr 19, 2023 | Sangon Biotech | Biotechnology | 290.4M |
Sangon BiotechExits
4
Funding Timeline
Funding rounds
11
Investors
0
Funds
0
Funding Rounds
11
GL Capital has raised 11 rounds. Their latest funding was raised on Apr 19, 2023 from a Venture Round - Sangon Biotech round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jun 07, 2022 | Series B - ImmunOs Therapeutics | - | 72.9M | - |
| Jun 07, 2022 | Series A - Nest | - | 0 | - |
| Nov 16, 2022 | Series A - Asia Pacific Medical Group | - | 0 | - |
| Apr 19, 2023 | Venture Round - Sangon Biotech | - | 290.4M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.